HEALTHWATCH
HIV/AIDS
Responding to HIV/AIDS Must Be
Team Effort
By James Allen and Patrick Sammon
The HIV/AIDS drug cocktail
has saved hundreds of thousands of lives in the
United States and around the globe, but after
the U.S. death rate fell in the late '90s, many
people mistakenly thought the disease was defeated.
At best, the current situation can be called a
standoff. As time progresses, the disease will
evolve to counter these medical advances, so pharmaceutical
companies will have to develop new drugs to combat
drug resistant strains of HIV. In the meantime,
individuals at risk for HIV cannot become complacent.
They must take necessary precautions
to prevent transmission of the disease. Unfortunately,
drug innovations have triggered complacency in
some individuals, leading them to engage in riskier
sexual behavior. As a result, infection rates
are on the rise. CDC figures confirm that HIV
infection rates among a number of demographic
groups are increasing. The figures, which report
new diagnoses of HIV infection, are based on 1999-2002
data from 29 states and the U.S. Virgin Islands.
Source
Striking increases in new diagnoses
have occurred in a number of the groups. Those
over the age of 45, Hispanics, and men engaging
in homosexual sex saw the largest increases. While
Hispanics were the racial group seeing the greatest
upsurge in HIV diagnoses, blacks still accounted
for the largest number of new diagnoses in sheer
numbers. In a troubling sign for the gay community,
homosexual sex among men was the mode of transmission
that had the most new diagnoses and the mode that
saw the greatest increase over the period.
To combat HIV and the rise
in infection rates, the private sector and government
should work together to develop useful solutions.
Also, individuals must take personal responsibility
for their behavior. Health care providers, including
pharmaceutical companies, must continue innovating
to develop even better treatment options. To make
sure this happens, the government response to
HIV/AIDS must recognize the importance of free
market principles. After all, innovation and improvement
will not happen from government alone; they also
depend on private industry.
To ensure that innovation continues,
the government must work to protect the intellectual
property rights of pharmaceutical companies. Drug
importation and weak patent protections will erode
the profit incentives that pharmaceutical companies
have to continue research and development on the
next generation of life-saving HIV/AIDS medication.
For their part, pharmaceutical companies need
to continue looking for ways to improve access
to their medications.
No matter what government or
the health care industry does to respond to HIV/AIDS,
individuals have to take personal responsibility
for their actions. People must realize that although
pharmaceutical companies have developed drugs
to battle HIV for a certain period of time, there
is still no cure for HIV. Accordingly, everyone
should avoid risky sexual behavior and IV drug
use.
Gay men, who account for the
greatest number of new HIV diagnoses, ought to
be particularly careful, reducing their number
of sexual partners, always using condoms, and
avoiding the use of recreational drugs. Crystal
methamphetamine (also known as crystal meth or
Tina), a drug most commonly used among gay men,
poses a particularly strong danger. Crystal meth
reduces people's inhibitions, increases the chances
they will not use condoms, and increases the likelihood
they will engage in group sex. Essentially, the
drug encourages some of the riskiest sexual behavior.
If gay men want to reduce their HIV infection
rate, they must not use this dangerous drug.
In addition, all sexually active
individuals must get tested for HIV frequently,
so they can take safeguards to avoid infecting
others with the virus. Our society's response
to HIV/AIDS must involve a shared responsibility
between government, pharmaceutical companies,
the entire health care industry and individuals.
This coordinated strategy is the most effective
way to battle this deadly disease.
back to
top | Back
to main HIV/AIDS
|